Project description
Improve detection and prevention of gallbladder cancer
Gallbladder carcinoma (GBC) is among the most aggressive cancers. It can only be cured at a very early stage. Unfortunately, GBC does not show signs and symptoms until it is in the advanced phase. Effective prevention and early diagnosis are needed. The EU-funded EULAT Eradicate GBC project will build a European-Latin America GBC biorepository connected to a computing platform that will enable research of the role, influence, and characteristics of a wide range of factors. The goal is to achieve faster detection. Novelty GBC biomarkers will be established. New epidemiological and molecular risks will be identified, leading to more accurate predictions, individualised prevention, and more targeted therapy. Innovative genomic alterations’ data in incidental GBC will enable further clinical trials.
Fields of science
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
69120 Heidelberg
Germany
See on map
Participants (13)
Valdivia
See on map
Temuco
See on map
3460000 Talca
See on map
69007 Lyon 7eme
See on map
10 Santiago
See on map
Lima
See on map
Cochabamba
See on map
0450 Oslo
See on map
A4400AWG Salta
See on map
8331150 Santiago
See on map
BS8 1QU Bristol
See on map
60596 Frankfurt Am Main
See on map
0313 Oslo
See on map